Promega Runs for Your Buns!
Please help us support Colon Cancer Coalition and colorectal cancer research by making a contribution to our team and sharing this page with your family and friends.
Colon cancer research has been ongoing at Promega for more than two decades, and has led to our recent submission to the US FDA for our first diagnostic product that is designed to detect microsatellite instability, a feature that informs oncologists about the likelihood that a patient has a hereditary condition that led to the development of colon cancer. This type of testing informs doctors about the type of treatment that is most likely to benefit the patient, and enables family members of those impacted to take preventive measures, reducing their likelihood of developing cancer as well.
Together, we can make a difference!